These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30151791)

  • 1. New Insights on the Pharmacokinetics of Ulifloxacin After Administration of Prulifloxacin in Patients with Mild, Moderate and Severe Renal Impairment.
    Tellone V; Coppola P; Ammendola M; Di Loreto G; Picollo R; Del Vecchio A; Comandini A; Garofolo F; Tongiani S
    Drugs R D; 2018 Sep; 18(3):237-245. PubMed ID: 30151791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penetration of orally administered prulifloxacin into human prostate tissue.
    Giberti C; Gallo F; Rosignoli MT; Ruggieri A; Barattè S; Picollo R; Dionisio P
    Clin Drug Investig; 2009; 29(1):27-34. PubMed ID: 19067472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penetration of prulifloxacin into gynaecological tissues after single and repeated oral administrations.
    Gorlero F; Lorenzi P; Rosignoli MT; Picollo R; Ruggieri A; Barattè S; Dionisio P
    Drugs R D; 2007; 8(6):373-81. PubMed ID: 17963428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penetration of orally administered prulifloxacin into human lung tissue.
    Concia E; Allegranzi B; Ciottoli GB; Orticelli G; Marchetti M; Dionisio P
    Clin Pharmacokinet; 2005; 44(12):1287-94. PubMed ID: 16372826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penetration of prulifloxacin into sinus mucosa of patients undergoing paranasal sinus elective endoscopic surgery.
    De Benedetto M; Passali D; Tomacelli G; Ruggieri A; Rosignoli MT; Picollo R; Bellussi L; Dionisio P
    J Chemother; 2012 Feb; 24(1):26-31. PubMed ID: 22546721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation among the toxicity profiling (28-days repeated oral dose toxicity), toxicokinetics and tissue distribution data of ulifloxacin, the active metabolite of prulifloxacin in Wistar albino rats.
    Nandi U; Roy B; Das AK; Pal TK
    Environ Toxicol Pharmacol; 2012 Sep; 34(2):588-607. PubMed ID: 22885677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transporter-mediated hepatic uptake of ulifloxacin, an active metabolite of a prodrug-type new quinolone antibiotic prulifloxacin, in rats.
    Yagi Y; Aoki M; Iguchi M; Shibasaki S; Kurosawa T; Kato Y; Tsuji A
    Drug Metab Pharmacokinet; 2007 Oct; 22(5):350-7. PubMed ID: 17965518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prulifloxacin.
    Keam SJ; Perry CM
    Drugs; 2004; 64(19):2221-34; discussion 2235-6. PubMed ID: 15456336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prulifloxacin: clinical studies of a broad-spectrum quinolone agent.
    Giannarini G; Tascini C; Selli C
    Future Microbiol; 2009 Feb; 4(1):13-24. PubMed ID: 19207096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a MEPS-UHPLC-PDA method for determination of ulifloxacin in human plasma and urine of patients with peripheral arterial disease.
    Ferrone V; Carlucci M; Palumbo P; Carlucci G
    J Pharm Biomed Anal; 2016 Sep; 128():313-321. PubMed ID: 27318081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of prulifloxacin on cardiac repolarization in healthy subjects: a randomized, crossover, double-blind versus placebo, moxifloxacin-controlled study.
    Rosignoli MT; Di Loreto G; Dionisio P
    Clin Drug Investig; 2010; 30(1):5-14. PubMed ID: 19995094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic characteristics of prulifloxacin.
    Matera MG
    Pulm Pharmacol Ther; 2006; 19 Suppl 1():20-9. PubMed ID: 16360331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of ulifloxacin, the active metabolite of prulifloxacin, in human plasma by a 96-well format solid-phase extraction and capillary zone electrophoresis.
    Zhang L; Wen J; Pan Y; Li Z; Fan G; Wu Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Sep; 872(1-2):172-6. PubMed ID: 18706872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 14-day prulifloxacin treatment of acute uncomplicated cystitis in women with recurrent urinary tract infections: a prospective, open-label, pilot trial with 6-month follow-up.
    Cai T; Mazzoli S; Nesi G; Boddi V; Mondaini N; Bartoletti R
    J Chemother; 2009 Nov; 21(5):535-41. PubMed ID: 19933045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of the active metabolite of prulifloxacin in human plasma by liquid chromatography-tandem mass spectrometry.
    Guo L; Qi M; Jin X; Wang P; Zhao H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Mar; 832(2):280-5. PubMed ID: 16490405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a liquid chromatography-tandem mass spectrometry method to determine ulifloxacin, the active metabolite of prulifloxacin in rat and rabbit plasma: application to toxicokinetic study.
    Roy B; Choudhury H; Das A; Das AK; Pal TK
    Biomed Chromatogr; 2011 Aug; 25(8):890-901. PubMed ID: 21154639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palbociclib (PD-0332991) pharmacokinetics in subjects with impaired renal function.
    Yu Y; Hoffman J; Plotka A; O'Gorman M; Shi H; Wang D
    Cancer Chemother Pharmacol; 2020 Dec; 86(6):701-710. PubMed ID: 33037918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and tolerability of prulifloxacin after single oral administration.
    Picollo R; Brion N; Gualano V; Millérioux L; Marchetti M; Rosignoli MT; Dionisio P
    Arzneimittelforschung; 2003; 53(3):201-5. PubMed ID: 12705176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prulifloxacin versus levofloxacin in the treatment of severe COPD patients with acute exacerbations of chronic bronchitis.
    Blasi F; Schaberg T; Centanni S; Del Vecchio A; Rosignoli MT; Dionisio P
    Pulm Pharmacol Ther; 2013 Oct; 26(5):609-16. PubMed ID: 23538168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delafloxacin Pharmacokinetics in Subjects With Varying Degrees of Renal Function.
    Hoover RK; Alcorn H; Lawrence L; Paulson SK; Quintas M; Cammarata SK
    J Clin Pharmacol; 2018 Apr; 58(4):514-521. PubMed ID: 29251785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.